A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)

Clinical trial NCT06708286 · COMPLETED

Trial details

NCT number: NCT06708286
Sponsor: CanSino Biologics Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis

Start date: 2024-12-20
Primary completion: 2025-07-01
Enrollment: 1820

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.